Emre Yekedüz

About Emre Yekedüz

Emre Yekedüz, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at Ankara Üniversitesi, specializes in the field of Medical Oncology, Genitourinary Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function

Seguridad y eficacia de nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal

The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study

Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients

Immunotherapy for Metastatic Prostate Carcinoma

Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

Thromboembolic Risk in Prostate Cancer Patients Treated with PARP Inhibitors: A Systematic Review and Meta-analysis

Combination Therapies in Patients with Favorable Risk Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Emre Yekedüz Information

University

Position

Faculty of Medicine Department of Medical Oncology

Citations(all)

327

Citations(since 2020)

321

Cited By

50

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Emre Yekedüz Skills & Research Interests

Medical Oncology

Genitourinary Oncology

Top articles of Emre Yekedüz

Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function

2024/4/1

Seguridad y eficacia de nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal

2024/3/8

The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study

International Journal of Cancer

2024/2/15

Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients

Anti-Cancer Drugs

2024/2/1

Emre Yekedüz
Emre Yekedüz

H-Index: 3

Ahmet Demirkazik
Ahmet Demirkazik

H-Index: 11

Immunotherapy for Metastatic Prostate Carcinoma

Turkiye Klinikleri Medical Oncology-Special Topics

2024

Emre Yekedüz
Emre Yekedüz

H-Index: 3

Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

Clinical Genitourinary Cancer

2024/6/1

Thromboembolic Risk in Prostate Cancer Patients Treated with PARP Inhibitors: A Systematic Review and Meta-analysis

2024/4/27

Combination Therapies in Patients with Favorable Risk Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

2023/12/10

Emre Yekedüz
Emre Yekedüz

H-Index: 3

1794P Prognostic role of metastatic site in patients with de novo metastatic prostate cancer: A population-based analysis in new hormonal agents era

Annals of Oncology

2023/10/1

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

Journal of Cancer Research and Clinical Oncology

2023/9

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer

2023/7/1

Emre Yekedüz
Emre Yekedüz

H-Index: 3

The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study

Journal of Cancer Research and Clinical Oncology

2023/7

Kanser Ağrısı

2023/5/26

The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab‐containing regimens

ANZ Journal of Surgery

2023/4

Emre Yekedüz
Emre Yekedüz

H-Index: 3

Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

2023/1/2

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium …

Clinical Genitourinary Cancer

2023/2/1

Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience

Journal of Oncological Science

2023

Emre Yekedüz
Emre Yekedüz

H-Index: 3

Deniz Güven
Deniz Güven

H-Index: 3

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

Urologia Internationalis

2023

The relationship between systemic immune-inflammation indexes and treatment response in locally advanced esophageal cancer

Anatolian Current Medical Journal

2023/1/1

Emre Yekedüz
Emre Yekedüz

H-Index: 3

Vortex keratopathy associated with ribociclib

Journal of Oncology Pharmacy Practice

2023/1

Emre Yekedüz
Emre Yekedüz

H-Index: 3

See List of Professors in Emre Yekedüz University(Ankara Üniversitesi)